Michael Way obtained his PhD from the University of Cambridge, UK, and received postdoctoral training at the Medical Research Council Laboratory of Molecular Biology, Cambridge, UK, and the Whitehead Institute, Massachusetts Institute of Technology in Cambridge, MA, USA. He was a group leader in the Cell Biology Programme at the European Molecular Biology Laboratory, Heidelberg, Germany, for 6.5 years before moving to the Cancer Research UK London Research Institute in 2001. The goal of Dr Way's research is to understand how signalling networks and their underlying machinery regulate cytoplasmic transport and cell migration. He has been a JCS Editor since 2005, and Editor-in-Chief since 2012.

Areas of expertise: Actin, cytoskeleton, GTPases, microtubules, motility, myosin and kinesin motors, signalling (phospho-tyrosine and SH2/SH3 adaptor type), viruses.